Dyadic International, Inc. DYAI
$0.78
+0.65%
at last close
Market Cap$32.07 million
P/E Ratio—
Div Yield—
Volume164.3K
52-Week Range
$0.65$1.60
Analyst Ratings
- Consensus
- Buy — 1 Buy · 0 Hold · 0 Sell (1 analysts)
- Avg. Price Target
- $3.00 (+287.0% upside)
Key Stats
- Today's Range
- $0.75 – $0.82
- 50-Day Range
- $0.66 – $1.60
- 52-Week Range
- $0.65 – $1.60
- Volume
- 164K shs
- Average Volume
- 251K shs
- Market Cap
- $32.07 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.01%
- Days to Cover
- 1.00
About Dyadic International, Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Related Stocks
Compare head-to-head: DYAI vs AMGN·DYAI vs HALO·DYAI vs KYMR·DYAI vs RGEN
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.